Adam Roughley

771 total citations
15 papers, 561 citations indexed

About

Adam Roughley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Adam Roughley has authored 15 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Adam Roughley's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Eosinophilic Esophagitis (2 papers). Adam Roughley is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Eosinophilic Esophagitis (2 papers). Adam Roughley collaborates with scholars based in United Kingdom, United States and Switzerland. Adam Roughley's co-authors include Gavin Taylor‐Stokes, Shrividya Iyer, A. Rider, James Piercy, Victoria Higgins, Andrea Leith, James Siddall, M Benford, Gary Milligan and Alpesh Amin and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Nephrology Dialysis Transplantation.

In The Last Decade

Adam Roughley

15 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Roughley United Kingdom 7 272 236 90 80 64 15 561
Peter Nieboer Netherlands 14 210 0.8× 134 0.6× 61 0.7× 49 0.6× 54 0.8× 30 472
Efstathios Zikos Belgium 11 390 1.4× 179 0.8× 99 1.1× 94 1.2× 39 0.6× 17 622
J. Schmucker-Von Koch Germany 6 389 1.4× 181 0.8× 110 1.2× 106 1.3× 36 0.6× 10 618
Gavin Taylor‐Stokes United Kingdom 17 453 1.7× 428 1.8× 121 1.3× 91 1.1× 65 1.0× 48 993
B. B. Reeve United States 3 344 1.3× 159 0.7× 123 1.4× 115 1.4× 34 0.5× 5 563
David Cella United States 7 372 1.4× 370 1.6× 66 0.7× 71 0.9× 32 0.5× 17 751
Brandon A. Mahal United States 14 233 0.9× 301 1.3× 56 0.6× 59 0.7× 25 0.4× 69 703
Laura Venditti United States 8 340 1.3× 142 0.6× 58 0.6× 78 1.0× 25 0.4× 8 653
Monika Sztankay Austria 16 395 1.5× 121 0.5× 150 1.7× 149 1.9× 24 0.4× 50 648
Peter Heathcote Australia 13 388 1.4× 431 1.8× 102 1.1× 75 0.9× 41 0.6× 36 952

Countries citing papers authored by Adam Roughley

Since Specialization
Citations

This map shows the geographic impact of Adam Roughley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Roughley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Roughley more than expected).

Fields of papers citing papers by Adam Roughley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Roughley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Roughley. The network helps show where Adam Roughley may publish in the future.

Co-authorship network of co-authors of Adam Roughley

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Roughley. A scholar is included among the top collaborators of Adam Roughley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Roughley. Adam Roughley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Barratt, Jonathan, et al.. (2023). #3081 ASSOCIATION OF URINE PROTEIN EXCRETION LEVELS, AS A MEASURE OF DISEASE ACTIVITY, AND QUALITY OF LIFE IN IGA NEPHROPATHY PATIENTS. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
2.
Ding, Zhijie, et al.. (2022). Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States. Crohn s & Colitis 360. 4(3). otac023–otac023. 10 indexed citations
3.
Byrne, Katherine, et al.. (2018). Real-World Treatment Patterns and Outcomes of Patients with Stage IV Squamous Cell Carcinoma of the Head and Neck. Future Oncology. 15(6). 611–623. 3 indexed citations
4.
Amin, Alpesh, Vaidyanathan Ganapathy, Adam Roughley, & Mark Small. (2017). Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease. Patient Preference and Adherence. Volume 11. 1205–1212. 33 indexed citations
5.
Buchanan, Jacqueline, et al.. (2017). Humanistic burden of disease in earlier stage metastatic (stage IIIb/c-IVM1a) versus late stage metastatic (IVM1b/c) melanoma patients in a real-world setting in the U.S.. Journal of Clinical Oncology. 35(15_suppl). 9561–9561. 1 indexed citations
6.
Higgins, Victoria, James Piercy, Adam Roughley, et al.. (2016). Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metabolic Syndrome and Obesity. Volume 9. 371–380. 161 indexed citations
7.
Mozaffarian, Neelufar, et al.. (2016). Satisfaction with control of systemic lupus erythematosus and lupus nephritis: physician and patient perspectives. Patient Preference and Adherence. Volume 10. 2051–2061. 11 indexed citations
8.
Lin, Hui‐Ming, et al.. (2015). Impact Of Staging And Hormone Sensitivity On Quality Of Life In Us Prostate Cancer Patients. Value in Health. 18(7). A468–A468. 1 indexed citations
9.
Piercy, James, A. Burak Ozbay, Adam Roughley, Jingdong Chao, & Martha Skup. (2015). Tu1256 Comparison of Ulcerative Colitis With Crohn's Disease From the Perspective of Patient Burden. Gastroenterology. 148(4). S–839. 2 indexed citations
10.
Roughley, Adam, et al.. (2014). Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer. Value in Health. 17(7). A650–A650. 22 indexed citations
11.
Rizzetto, Mario, Kelly M. Grotzinger, Dickens Theodore, et al.. (2014). Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries. Journal of Viral Hepatitis. 21(10). e129–34. 3 indexed citations
12.
Iyer, Shrividya, Adam Roughley, A. Rider, & Gavin Taylor‐Stokes. (2013). The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study. Supportive Care in Cancer. 22(1). 181–187. 165 indexed citations
13.
Iyer, Shrividya, Gavin Taylor‐Stokes, & Adam Roughley. (2013). Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. 81(2). 288–293. 146 indexed citations
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Nieboer Breakdown of academic impact, for papers by Efstathios Zikos Breakdown of academic impact, for papers by J. Schmucker-Von Koch Breakdown of academic impact, for papers by Gavin Taylor‐Stokes Breakdown of academic impact, for papers by B. B. Reeve Breakdown of academic impact, for papers by David Cella Breakdown of academic impact, for papers by Brandon A. Mahal Breakdown of academic impact, for papers by Laura Venditti Breakdown of academic impact, for papers by Monika Sztankay Breakdown of academic impact, for papers by Peter Heathcote
Rankless by CCL
2026